Conventional T1 and T2 weighted MRI are ubiquitously used to diagnose and monitor disease progression in multiple sclerosis, but are only sensitive to later-stage inflammatory lesions and atrophy. Imaging biomarkers sensitive to tissue changes earlier in disease pathology may have significant implications in the diagnosis and prognosis of MS. Quantitative magnetization transfer (qMT) and chemical exchange saturation transfer (CEST) MRI have shown sensitivity to macromolecules and tissue biochemistry, respectively. In this work, we investigate quantitatively derived metrics from qMT and CEST as potential biomarkers for pathological changes which precede lesion formation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords